Celltrion
068270.KS
#887
Rank
$18.39 B
Marketcap
$133.07
Share price
2.02%
Change (1 day)
-25.99%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2022 (TTM): $0.57 B

According to Celltrion 's latest financial reports the company's current earnings (TTM) are $0.57 B. In 2021 the company made an earning of $0.60 B an increase over its 2020 earnings that were of $0.56 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$0.57 B-5.87%
2021$0.60 B7.33%
2020$0.56 B68.28%
2019$0.33 B15.33%
2018$0.29 B-34.22%
2017$0.44 B109.94%
2016$0.21 B25.57%
2015$0.16 B-7.42%
2014$0.18 B35.2%
2013$0.13 B-26.97%
2012$0.18 B
2010$95.83 M72.84%
2009$55.44 M260.54%
2008$15.37 M